Showing 116 news articles about Drug interactions & pharmacokinetics

Filters Content type: Editors' picks Topic: Drug interactions & pharmacokinetics

Taking two or more different drugs together may result in an alteration in the effectiveness or in the side-effects of one or more of the drugs. Pharmacokinetics (PK) is the study of how a drug is absorbed into the body and distributed in different parts of the body. Pharmacodynamics (PD) is the study of the impact of different concentrations of a drug on the body.

Drug interactions & pharmacokinetics

Risk of Harmful Drug Interactions Rises With Age in HIV+ US Group

Editor's pick
International AIDS Society
26 November 2013
Drug interactions & pharmacokinetics

Merck plans phase III study of once-daily raltegravir (Isentress)

Editor's pick
Merck press release
16 October 2013
New & experimental HIV treatments

European Commission Approves Gilead Sciences' Tybost(TM), a New Boosting Agent for HIV Therapy

Editor's pick
Gilead press release
26 September 2013
TB treatment

Adding Blood Pressure Drug to Standard Antibiotics Speeds Up TB Treatment

Editor's pick
Johns Hopkins Medicine press release
2 September 2013
Drug interactions & pharmacokinetics

Trials challenging HIV drug doses could usher in huge cost cuts

Editor's pick
Nature Medicine
7 August 2013
New & experimental HIV treatments

Nanoparticles May Transport HIV Meds to the Brain

Editor's pick
AIDSMeds
16 May 2013
New & experimental HIV treatments

Protease Inhibitors Boost Levels of Cenicriviroc, a CCR5/CCR2 Antagonist

Editor's pick
NATAP
14 May 2013
Drug interactions & pharmacokinetics

Changes to label for Atripla tablets

Editor's pick
FDA
18 April 2013
Drug interactions & pharmacokinetics

Prezista (darunavir) label change - drug interaction information

Editor's pick
US Food and Drug Administration
2 March 2013
Treatment guidelines

Updated HIV Treatment Guidelines Include Stronger Recommendation for Acute Infection

Editor's pick
HIVandHepatitis.com
15 February 2013
Hepatitis C treatment side-effects

Drug interaction warning for hepatitis C: serious side effects when using telaprevir and bosentan

Editor's pick
CATIE
15 February 2013
Hepatitis C treatment side-effects

Copy of Drug interaction warning for hepatitis C: serious side effects when using telaprevir and bosentan

Editor's pick
CATIE
15 February 2013
Treatment guidelines

Updated U.S. DHHS guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents

Editor's pick
AIDSinfo
15 February 2013
Drug interactions & pharmacokinetics

Certain Meds Mixed With Grapefruit Juice Can Be a Fatal Cocktail

Editor's pick
AIDSMeds
21 December 2012
Drug interactions & pharmacokinetics

Mistakes are still commonly made in prescriptions of antiretroviral medications

Editor's pick
News Medical
22 October 2012
TB treatment

Tuberculosis: Combined wisdom

Editor's pick
The Economist
26 July 2012
HIV treatment for children & young people

Efavirenz Works in Kids with Both HIV and TB

Editor's pick
MedPage Today HIV/AIDS
25 July 2012
New & experimental HIV treatments

Similar Efficacy, Side Effects in Study of Gilead Booster Cobicistat and Norvir

Editor's pick
AIDSMeds
25 July 2012
TB treatment

UCSF/SFGH Researchers Call for Change in New FDA Recommendation on HIV and TB Drug Doses

Editor's pick
USCF News Center
24 July 2012
New & experimental HIV treatments

Gilead Files European Marketing Application for Boosting Agent Cobicistat

Editor's pick
Gilead press release
25 May 2012
Drug interactions & pharmacokinetics

13th International workshop on Clinical Pharmacology of HIV Therapy 16–18 April 2012, Barcelona

Editor's pick
i-base
23 May 2012
New & experimental hepatitis C treatment

US: do not mix Merck hepatitis pill with HIV drugs

Editor's pick
Reuters
27 April 2012
New & experimental hepatitis C treatment

No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine & Etravirine

Editor's pick
NATAP
20 April 2012
Drug interactions & pharmacokinetics

Genetic testing for drug intolerance

Editor's pick
The Guardian
16 April 2012